SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : T/FIF, a New Plateau -- Ignore unavailable to you. Want to Upgrade?


To: scaram(o)uche who wrote (305)11/1/2000 5:55:08 PM
From: scaram(o)uche  Respond to of 2243
 
trickle, trickle.....

Wednesday November 1, 4:53 pm Eastern Time

Press Release

Third Quarter Sales Surge at Charles River
Laboratories

WILMINGTON, Mass.--(BW HealthWire)--Nov. 1, 2000--Charles River Laboratories International, Inc.'s (NYSE:CRL -
news) sales increased 37% in the third quarter over the prior year, driven by strong growth in customer demand for its drug
discovery and development products and services.
(snip)

While I was a Jackson Labs snob, some of us were buying rodents from this company in the '70s. This is an old, established company, and a 37% increase in sales is a true indicator of trickle. BTW.... this is also where the BTRN miniswine herd is housed.



To: scaram(o)uche who wrote (305)11/2/2000 2:03:57 AM
From: Spekulatius  Read Replies (2) | Respond to of 2243
 
Well my guess for Rick's 100 bagger is good ole MCDE.
My personal tip for this sort of performance is GZMO, but what do I know ? Also, at 14$/share its already getting too pricey for Rick <G>.



To: scaram(o)uche who wrote (305)11/3/2000 6:26:04 AM
From: dalroi  Respond to of 2243
 
Never looked at FOCL. Should we?

in retrospect for trading purpouse YES

cheers
Stefaan